The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlfa Fin Regulatory News (ALFA)

Share Price Information for Alfa Fin (ALFA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 182.00
Bid: 180.20
Ask: 181.80
Change: 3.80 (2.13%)
Spread: 1.60 (0.888%)
Open: 179.60
High: 182.00
Low: 175.80
Prev. Close: 178.20
ALFA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Alfa Financial Software Holdings plc

2 Oct 2023 08:21

Form 8.5 (EPT/RI) - Alfa Financial Software Holdings plc

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the “Code”)

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:Investec Bank plc
(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Alfa Financial Software Holdings Plc
(c) Name of the party to the offer with which exempt principal trader is connected:Investec is Advisor and Joint Broker to Alfa Financial Software Holdings Plc
(d) Date dealing undertaken:29th September 2023
(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state “N/A” No

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant securityPurchases/ sales Total number of securitiesHighest price per unit paid/receivedLowest price per unit paid/received
Ordinary Shares Purchases 200,000 185 183,75
Ordinary Shares Sales 175,177 185.25 183

 

(b) Cash-settled derivative transactions

 

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
     

 

(c) Stock-settled derivative transactions (including options)

 

 

(i) Writing, selling, purchasing or varying

 

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
        

 

(ii) Exercise

 

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
     

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
    

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
 

 

 

Date of disclosure:2nd October 2023
Contact name:Jacq Lovis
Telephone number:+44 207 597 4815

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
12th Oct 20204:47 pmRNSDirector/PDMR Shareholding
7th Oct 20204:54 pmRNSDirector/PDMR Shareholding
5th Oct 20209:39 amRNSDirector Declaration
29th Sep 20207:00 amRNS2020 Half-year Report
25th Aug 20207:00 amRNSTrading Update
22nd Jul 20207:00 amRNSChange of auditors and date of interim results
13th Jul 20207:00 amRNSChange of corporate broker and trading update
9th Jul 20204:40 pmRNSSecond Price Monitoring Extn
9th Jul 20204:35 pmRNSPrice Monitoring Extension
11th Jun 20203:26 pmRNSResult of AGM
10th Jun 20204:41 pmRNSSecond Price Monitoring Extn
10th Jun 20204:35 pmRNSPrice Monitoring Extension
4th Jun 20207:00 amRNSDirector/PDMR Shareholding
13th May 20206:32 pmRNSNotice of 2020 Annual General Meeting
6th May 202010:24 amRNSPublication of 2019 Annual Report and Accounts
5th May 20207:00 amRNSContract
30th Apr 20203:00 pmRNSDirector/PDMR Shareholding
28th Apr 20209:45 amRNSDirector/PDMR Shareholding
23rd Apr 202012:02 pmRNSPrice Monitoring Extension
23rd Apr 20207:00 amRNS2019 Preliminary Results Announcement
16th Apr 20207:00 amRNSNotice of Results
30th Mar 20207:00 amRNSContract
25th Mar 20207:00 amRNSAppointment of Directors
24th Mar 202012:08 pmRNSSecond Price Monitoring Extn
24th Mar 202012:02 pmRNSPrice Monitoring Extension
23rd Mar 20207:00 amRNSDirectorate Change
18th Mar 202011:23 amRNSContract
4th Mar 20207:00 amRNSContract
14th Feb 20207:00 amRNSContract
9th Jan 20205:01 pmRNSHolding(s) in Company
16th Dec 201910:11 amRNSHolding(s) in Company
19th Nov 20197:00 amRNSContract
8th Nov 20197:00 amRNSContract
7th Nov 20192:55 pmRNSDirectorate Change
9th Oct 201911:29 amRNSAppointment of a Director
26th Sep 20194:26 pmRNSNotification of Major Holdings
26th Sep 20197:00 amRNSHalf-year Report
16th Sep 20197:00 amRNSTrading Update and Notice of Results
20th Aug 20198:00 amRNSAppointment of a Director
9th Aug 20198:00 amRNSAppointment of a Director
18th Jul 201912:05 pmRNSDirectorate Change
26th Apr 20195:12 pmRNSResult of AGM
4th Apr 20197:00 amRNSDirectorate Change
19th Mar 20195:00 pmRNSAnnual Financial Report
7th Mar 20197:00 amRNSFinal Results
11th Feb 20197:09 amRNSDirector Declaration
23rd Jan 20191:53 pmRNSDirectorate Change and Notice of Results
21st Jan 20191:12 pmRNSNotification of Major Shareholder
4th Sep 20187:00 amRNSHalf-year Report
23rd Aug 20187:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.